FhHDM-1p2

General Information


DRACP ID  DRACP03828

Peptide Name   FhHDM-1p2

Sequence  AMAYLAKDNLGEKITEVITILLNRLTDRLEKYAG

Sequence Length  34

UniProt ID  F6KNY7 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C171H287N45O52S

Absent amino acids  CFHPQSW

Common amino acids  L

Mass  442632

Pl  6.66

Basic residues  5

Acidic residues  5

Hydrophobic residues  14

Net charge  0

Boman Index  -4584

Hydrophobicity  -3.24

Aliphatic Index  123.53

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  90.3

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23875042

Title  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13415

DRACP is developed by Dr.Zheng's team.